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The Spanish influenza pandemic of 1918 to 1919 swept the globe and resulted in the deaths of at least 20
million people. The basis of the pulmonary damage and high lethality caused by the 1918 H1N1 influenza virus
remains largely unknown. Recombinant influenza viruses bearing the 1918 influenza virus hemagglutinin (HA)
and neuraminidase (NA) glycoproteins were rescued in the genetic background of the human A/Texas/36/91
(H1N1) (1918 HA/NA:Tx/91) virus. Pathogenesis experiments revealed that the 1918 HA/NA:Tx/91 virus was
lethal for BALB/c mice without the prior adaptation that is usually required for human influenza A H1N1
viruses. The increased mortality of 1918 HA/NA:Tx/91-infected mice was accompanied by (i) increased (>200-
fold) viral replication, (ii) greater influx of neutrophils into the lung, (iii) increased numbers of alveolar
macrophages (AMs), and (iv) increased protein expression of cytokines and chemokines in lung tissues
compared with the levels seen for control Tx/91 virus-infected mice. Because pathological changes in AMs and
neutrophil migration correlated with lung inflammation, we assessed the role of these cells in the pathogenesis
associated with 1918 HA/NA:Tx/91 virus infection. Neutrophil and/or AM depletion initiated 3 or 5 days after
infection did not have a significant effect on the disease outcome following a lethal 1918 HA/NA:Tx/91 virus
infection. By contrast, depletion of these cells before a sublethal infection with 1918 HA/NA:Tx/91 virus
resulted in uncontrolled virus growth and mortality in mice. In addition, neutrophil and/or AM depletion was
associated with decreased expression of cytokines and chemokines. These results indicate that a human
influenza H1N1 virus possessing the 1918 HA and NA glycoproteins can induce severe lung inflammation
consisting of AMs and neutrophils, which play a role in controlling the replication and spread of 1918
HA/NA:Tx/91 virus after intranasal infection of mice.
The influenza pandemic of 1918 was exceptional in that it
resulted in an estimated 20 to 50 million deaths worldwide (9,
32, 50, 59). Approximately 30% of the world’s population was
clinically infected during the pandemic (15), and there was an
unusually high lethality rate among healthy adults aged 15 to
34 years, a finding that has not been observed in subsequent
pandemics or epidemics caused by influenza A viruses (40).
Histopathological analysis of lung tissues from individuals who
died from primary influenza pneumonia in 1918 showed mas-
sive pulmonary edema with unique destruction of the alveolar
architecture (35, 58, 72). The retrieval of viral RNA from
archived autopsy materials and from the body of an Alaskan
influenza victim buried in permafrost has revealed the genetic
code of this H1N1 subtype influenza virus. Analyses of the
complete coding sequences of the 1918 hemagglutinin (HA),
neuraminidase (NA), matrix, nonstructural, and nucleoprotein
genes have not revealed the molecular basis for its extreme
virulence (4, 48–52, 58).
Plasmid-based reverse genetics has allowed for the generation
of recombinant viruses containing one or more of the 1918 influ-
enza virus genes entirely from cloned cDNAs (4, 19, 30, 34, 64,
65). Using this approach, we previously generated recombinant
viruses possessing the 1918 HA and/or NA segments rescued on
the genetic background of the mouse-adapted A/WSN/33 (1918
HA/NA:WSN) virus (30, 64, 65). Although the full virulence of
the 1918 pandemic virus is most likely due to the constellation
of virus genes, initial emphasis was placed on the HA and NA
glycoproteins (30, 34, 64, 65), since they are the major viral
surface antigens and are important virulence factors in birds
and mammals (22, 25, 44, 74). Infection with the 1918 HA/NA:
WSN virus resulted in severe morbidity and mortality in
BALB/c mice, whereas a recombinant control virus possessing
the HA and NA of the contemporary A/New Caledonia/20/99
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(H1N1) virus (N. Cal. HA/NA:WSN) induced minimal lung
pathology and was not lethal. Histological characterization of
1918 HA/NA:WSN-infected mouse lungs demonstrated severe
pulmonary lesions consisting of severe bronchitis and alveolitis
as early as 72 h following an intranasal infection (30). More-
recent studies by Kobasa et al. (34) confirmed these results and
also indicated that the 1918 HA alone confers increased rep-
lication properties and lethality in mice to human influenza
viruses. Additional studies are needed to further characterize
the pulmonary inflammation and the functional roles of in-
flammatory cells that contribute to the unique pathogenic
properties observed with the 1918 HA and NA recombinant
influenza viruses.
In its uncomplicated form, a human influenza A virus infec-
tion of the H1 or H3 subtype results in viral replication in the
respiratory epithelium and leads to the induction of an inflam-
matory infiltrate comprised mainly of mononuclear leukocytes,
with lower levels of polymorphonuclear leukocytes (neutro-
phils) (1). Recovery from influenza infection is dependent on
virus-specific T and B cells (10, 20, 74). However, neutrophils
and alveolar macrophages (AMs) can respond more quickly to
virus infection and play important roles in the pulmonary dis-
ease process (23, 54, 56). AMs are the primary mononuclear
phagocytes of the uninflamed lung alveoli and are considered
the first cells of the immune system to encounter inhaled or-
ganisms and antigens. Therefore, they function as the major
scavenger cells in the lower respiratory tract, and upon appro-
priate stimulation, these cells can release proinflammatory
cytokines and chemokines (5, 39, 54). Neutrophils may also
contribute to the release of cytokines, and although they tra-
ditionally have been viewed as being important in fighting
bacterial infections, these cells can be involved in virally in-
duced pathology (46, 62, 67).
The basis for the exceptional virulence of the 1918 pandemic
influenza virus remains elusive but most certainly involves host
responses to influenza infection. Because little is known about
the mechanism(s) by which the 1918 influenza virus caused
severe lung pathology and death, this study was undertaken to
investigate the pathogenesis in mice of a recombinant influ-
enza virus possessing the 1918 HA and NA glycoproteins. The
genetic background of the remaining influenza genes used for
the recombinant 1918 virus was derived from a human influ-
enza A H1N1 1991 strain, A/Texas/36/91 (1918 HA/NA:Tx/91)
virus, which has been characterized in humans under experi-
mental settings (26) and is nonpathogenic in mice. Character-
ization of the 1918 HA/NA:Tx/91 virus revealed a high patho-
genicity phenotype in mice in comparison to that of the
parental Tx/91 virus. An additional feature of the lethal 1918
HA/NA:Tx/91 virus was its ability to induce elevated levels of
cytokines, AMs, and neutrophils in the infected mouse lung.
While increased numbers of AMs and neutrophils in lungs
contribute to the inhibition of virus replication as part of the
host innate immune response, they might also contribute to the
enhanced immunopathology and, therefore, be partially re-
sponsible for the lethal phenotype of the 1918 HA/NA:Tx/91
virus. Using depletion techniques, we found that these cells
play a role in the initial stages of the innate immune response
in limiting virus replication, virus spread, and lethality during
1918 HA/NA:Tx/91 virus infection.
MATERIALS AND METHODS
Generation of 1918 HA and NA cDNAs and recombinant viruses. The 1918
HA and NA cDNAs were constructed by PCR with overlapping deoxyoligonu-
cleotides corresponding to the published sequence of the influenza A/South
Carolina/1/18 (H1N1) virus HA (48) open reading frame or the influenza A/Bre-
vig Mission/1/18 (H1N1) virus NA open reading frame (49). The noncoding
regions of each segment are identical to those of the corresponding segment of
influenza A/WSN/33 (WSN) H1N1 virus. Recombinant viruses were generated
using the reverse genetics system of Fodor et al. (14) following the methods of
Basler et al. (4). Viruses possessing 1918 HA and NA genes in a WSN (1918
HA/NA:WSN) or 1918 HA/NA:Tx/91 virus background were generated under
biosafety level 3 (BSL-3 with enhancements) containment (3) to ensure the
safety of laboratory workers, the environment, and the public. All subsequent
laboratory and animal work with live virus also was performed under these
high-stringency containment conditions. The control viruses included a whole
parental Tx/91 virus rescued (rTx/91) in a similar manner and a wild-type Tx/91
stock provided by A. Klimov (Centers for Disease Control and Prevention,
Atlanta, Georgia). The identity of the 1918 influenza virus genes in the recom-
binant viruses was confirmed by reverse transcription-PCR and sequencing.
Primer sequences and PCR conditions are available upon request.
Infection of mice. Female BALB/c mice, 6 to 7 weeks old (Charles River
Laboratories, Wilmington, Mass.), were anesthetized with an intraperitoneal
(i.p.) injection of 0.2 ml of 2,2,2-tribromoethanal in tert-amyl alcohol (Avertin;
Aldrich Chemical Co., Milwaukee, Wis.), and 50 l of infectious virus diluted in
phosphate-buffered saline (PBS) was inoculated intranasally (i.n.). Fifty-percent
lethal dose (LD50) titers were determined by inoculating groups of three mice i.n.
with serial 10-fold dilutions of virus. LD50 titers were calculated by the method
of Reed and Muench (47). For determination of lung virus titers, morbidity
(measured by weight loss), and mortality at multiple time points during the first
week of infection, 24 additional mice were infected i.n. with the highest inocu-
lating dose (106 PFU) of virus. Individual body weights from eight mice were
recorded for each group on days 0, 2, 4, 6, 8, and 10 postinfection (p.i.) and
monitored daily for disease signs and death for 14 days p.i. On days 2, 4, 6, and
8 p.i., four mice from each group were euthanatized, and whole lungs, spleen,
and brain tissues were removed aseptically and homogenized in 1 ml of sterile
PBS. After this process, homogenates were titrated for virus infectivity in 10-
day-old embryonated eggs (36). The statistical significance of virus titer data was
determined by using analysis of variance (ANOVA). Fifty-percent egg infectious
dose (EID50/ml) titers were calculated by the method of Reed and Muench (47).
Lung homogenates along with bronchoalveolar lavage (BAL) samples (de-
scribed below) were also individually tested for bacterial infection by routine
bacteriological methods for the isolation and identification of bacteria. Briefly,
serial 10-fold dilutions of lung homogenates (day 4 p.i.) or BAL samples (days 0,
3, 5, and 7 p.i.) were transferred to a tryptic soy agar plate, blood agar, chocolate
agar, or a MacConkey agar plate (Fisher Scientific, Pittsburgh, PA). Five lung
homogenates collected on day 4 p.i. and 20 BAL samples collected on p.i. days
0, 3, 5, and 7 per group were tested from both the mock control and infected
groups. Three individual bacteriological loops were plated from each sample,
and the number of CFU was determined after 72 h of incubation at 37°C.
Histopathology. Three mice from each group were euthanatized on day 5 p.i.
A 5-mm lung sample from the ventral end of each left lobe was collected for
histopathology, as were brain, lung, heart, spleen, liver, kidney, thymus, and
bronchial lymph node samples. Duplicate sections were immunohistochemically
stained to demonstrate influenza A viral protein. The primary antibody was
produced in chickens that had been immunized twice with A/chicken/Wiscon-
sin/68 (H5N9) virus and was used at a 1:100 dilution. This antibody recognizes
conserved internal virus proteins of multiple subtypes. The secondary antibody
was a goat anti-chicken immunoglobulin G (IgG) tagged with horseradish per-
oxidase (Southern Biotech, Birmingham, AL), and the chromogen diamino-
benzidine (DAB Plus kit; Zymed, San Francisco, CA) was used for visualization.
For the lung sections, the numbers of all viral antigen-positive respiratory epi-
thelial cells and macrophages in a minimum of five high-powered fields (HPF)
were determined by counting, and averages were determined for individual mice
and for treatment groups.
BAL sample and blood cell counts. BAL sample cells were obtained from
euthanatized mice as previously described (31). Briefly, the BAL sample cells
were washed from the lungs of anesthetized mice in 1 ml of PBS containing 1%
bovine serum albumin (Sigma, St. Louis, MO). Absolute cell counts were per-
formed by diluting cell suspensions 1:5 in Turks solution (2% acetic acid, 0.01%
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methylene blue). The cell numbers from five individual mice per group were
determined in triplicate by counting in a hemocytometer. Portions were cytospun
onto glass microscope slides and stained with Hema 3 stain (Fisher Scientific),
and the percentages of monocytes, polymorphonuclear neutrophils, and lympho-
cytes were determined. At least 100 cells were counted for each slide; counts
were performed in triplicate at a magnification of 1,000. For differential cell
counts, peripheral blood samples (20 to 40 l) were obtained from the orbital
plexus of two or three mice on days 1, 3, 5, and 7 p.i., and smears were stained
with Hema 3 stain. For each sample, at least 100 cells were counted at a
magnification of1,000. The percentage of leukocytes was determined following
treatment with monoclonal antibody (MAb) RB6-8C5 or control rat IgG anti-
body (described below).
Depletion of neutrophils and AMs. The hybridoma RB6-8C5, which produces
a rat IgG2b anti-mouse granulocyte MAb, was a gift from R. Coffman, DNAX
Research Institute (Palo Alto, CA). The antibody was purified from hybridoma
culture medium by affinity chromatography with protein G-Sepharose Fast Flow
(Pharmacia, LKB Biotechnology, Piscataway, NJ) and quantified by use of a
radial immunodiffusion kit (ICN Immunobiologicals, Costa Mesa, Calif.). Each
mouse received one i.p. injection of 0.5 mg of purified antibody 5 h before
infection and another on day 3 p.i. To maintain sufficient depletion of neutro-
phils, mice received 1 mg of antibody on days 5 and 7 p.i. Control mice received
rat IgG antibody (Sigma) in place of MAb RB6-8C5. The same treatment
regimen also was followed for mice that received MAb RB6-8C5 treatment after
infection, except that the first i.p. injection of MAb RB6-8C5 was initiated on day
3 or 5 p.i. Thus, the first and second i.p. injections consisted of 0.5 mg of MAb
followed by 1 mg of antibody every other day. For depletion of AMs, liposome-
encapsulated dichloromethylene diphosphonate (clodronate) (L-CL2MDP) and
liposomes containing PBS (L-PBS) were prepared as previously described (66).
Dichloromethylene diphosphonate was a kind gift of Roche Diagnostics, Mann-
heim, Germany. BALB/c mice were anesthetized with Avertin before i.n. inoc-
ulation with L-CL2MDP or L-PBS in a 50-l volume on days 4 and 2 before
virus infection. In experiments where AMs were depleted after infection, mice
received L-CL2MDP or L-PBS on days 3 and 5 p.i or on days 5 and 7 p.i. This
procedure results in the selective depletion of AM so that other cells remain
unaffected after the elimination procedure (60, 69, 70). The toxicity of
L-CL2MDP was tested in five mice that were not later infected with virus. In
comparison to naı¨ve or L-PBS-treated mice, no overt signs of clinical illness,
including weight loss, were observed among animals that received L-CL2MDP.
Cytokine and chemokine quantitation. To determine the in vivo levels of
cytokine or chemokine proteins, five mice per group were exsanguinated from
the axilla and euthanatized, and lung tissues were removed from naı¨ve and
infected mice (day 5 p.i.). Individual whole-lung samples were immediately
frozen at 70°C. On the day of analysis, tissues were thawed, homogenized
in 1 ml of cold PBS, and centrifuged at 150  g for 5 min. The clarified cell
lysates were assayed for alpha interferon (IFN-; assay sensitivity,
12.5 pg/ml), IFN- (assay sensitivity, 2 pg/ml), tumor necrosis factor alpha
(TNF-; assay sensitivity, 5.1 pg/ml), macrophage inflammatory protein-1
alpha (MIP-1; assay sensitivity, 1.5 pg/ml), and MIP-2 (assay sensitivity,
1.5 pg/ml) by use of enzyme-linked immunosorbent assay (ELISA) kits pur-
chased from R & D Systems (Minneapolis, MN). Statistical significance of
lung cytokine data was determined by ANOVA.
RESULTS
Construction and characterization of recombinant viruses
with 1918 HA and NA influenza virus genes. Genes encoding
the 1918 pandemic influenza virus were reconstructed from
deoxyoligonucleotides and corresponded to the reported 1918
virus coding sequences (48, 49, 58). The HA and NA genes of
the 1918 virus rescued in the genetic background of Tx/91
(1918 HA/NA:Tx/91) or WSN (1918 HA/NA:WSN) virus had
high infectivity titers in MDCK cells and 10-day-old embryo-
nated chicken eggs, similar to those of the wild-type Tx/91,
rTx/91, and parental rescued WSN (rWSN) viruses (Table 1).
BALB/c mice were inoculated i.n., and weight loss, virus rep-
lication, and LD50 titers were determined. For comparison,
groups of mice were infected with the highly pathogenic 1918
HA/NA:WSN or rWSN virus, both of which were previously
shown to have high lethality in mice (65). Infection of mice
with the 1918 HA/NA:Tx/91 recombinant virus resulted in lung
virus titers that were approximately 250-fold higher than those
for rTx/91-infected mice on day 4 p.i. (Table 1). The 1918
HA/NA:WSN and rWSN viruses were more lethal (LD50
102.75) than the 1918 HA/NA:Tx/91 virus (LD50 of 10
4.75). In
contrast to the lethal outcomes of infection with the 1918
recombinant viruses, the rescued Tx/91 virus and its wild-type
counterpart did not kill mice and resulted in only minimal
weight reduction. To better understand the differences in
pathogenicity among the H1N1 recombinant viruses, we exam-
ined the kinetics of virus replication in lung, brain, and spleen,
the percent weight loss, and overall survival throughout the
course of 1918 HA/NA:Tx/91 virus infection. Mice infected i.n.
with 106 PFU of virus were sacrificed on days 2, 6, and 8 p.i. to
determine virus titers (Fig. 1A). On days 2 and 6 p.i., virus
titers recovered from the lungs of mice infected with the Tx/91
control viruses were significantly lower than those from the
1918 HA/NA:Tx/91-infected mice. 1918 HA/NA:Tx/91-in-
fected mice were unable to clear the infection, showed signs of
illness (e.g., ruffled fur and hunched posture), and began to
lose significant amounts of weight 4 days after infection
(Fig. 1B). Weight loss continued in 1918 HA/NA:Tx/91-in-
fected mice, and mortality reached 100% by day 8, with a mean
death time (MDT) of 7.3 days (Fig. 1C). In contrast, all Tx/
91-infected mice survived the infection and displayed minimal
weight reduction on day 2 p.i. only. We examined whether the
1918 HA/NA:Tx/91 virus replicated systemically in the mouse
by removing brain, heart, and spleen tissues on day 6 p.i. (four
samples per tissue), when virus titers in these tissues are max-
imal following infection with highly pathogenic influenza vi-
ruses (36). All eight mice infected with 1918 HA/NA:Tx/91 or
Tx/91 control viruses had undetectable levels of virus (100.8
EID50/ml) in the brain, heart, and spleen tissues (not shown).
Mouse lung pathology. The presence of gross and his-
topathologic changes and virus antigen in the mouse lung was
determined at 5 days p.i., a time that immediately preceded the
death of mice infected with the lethal 1918 HA/NA:Tx/91 virus.
The three mice infected with the control Tx/91 viruses had
normal lungs in terms of color, texture, and size, with only
occasional small dark red foci of pneumonia (Fig. 2a). Histo-
logically, the lungs were normal or had minimal-to-mild bron-
chitis with lymphocytic-to-histiocytic peribronchitis and mild
TABLE 1. Properties of recombinant influenza viruses
used in this study
Virusa
Titerb %
Weight
lossc
Lung titer
(log10
EID50/
ml  SE)d
LD50elog10
EID50/ml
PFU/ml
Wild-type Tx/36/91 8.2 2.0  107 0.7 3.3  0.2 6
Parental rTx/36/91 8.7 4.4  107 0.1 3.6  0.3 6
Parental rWSN 8.2 2.2  107 21.8 7.2 0.2 2.75
1918 HA/NA:Tx/36/91 8.7 2.5 107 15.9 6.0 0.2 4.75
1918 HA/NA:WSN 8.5 2.1 107 21.7 7.0 0.3 2.25
a All viral genomic segments derived from the WSN or Tx/91 virus unless
otherwise indicated.
b Calculated by the method of Reed and Muench (47) from titrations in eggs
and MDCK cells.
c Average percent weight loss on day 4 postinfection (five mice per group).
d Average lung titers of four mice on day 4 postinfection.
e Expressed as the log10 PFU required to give 1 LD50.
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histiocytic alveolitis (Fig. 2b and c). By contrast, mice infected
with the 1918 HA/NA:Tx/91 recombinant virus generally had
within the lungs large pneumonic areas primarily affecting the
ventral portions of each of the lung lobes (Fig. 2d). Histolog-
ically, a mild-to-severe necrotizing bronchitis with associated
moderate-to-severe alveolitis and moderate-to-severe pulmo-
nary edema was observed in these lungs (Fig. 2e). A striking
feature of the 1918 HA/NA:Tx/91-infected lungs was the prom-
inent number of neutrophils in the peribronchium and alveoli
(Fig. 2f). In comparing the two viruses, lungs from mice in-
fected with rTx/91 and from those infected with wild-type
Tx/91 virus groups had 14.2 and 9.9 neutrophils/HPF of alveoli,
respectively, while lungs from mice infected with 1918 HA/NA:
Tx/91 had 68.3 neutrophils/HPF of alveoli. To demonstrate
that a similar pathology could be induced with a second 1918
HA/NA recombinant virus, three mice were infected with the
1918 HA/NA:WSN virus, and histopathologic changes were
determined at day 5 p.i. The lungs from the 1918 HA/NA:
WSN-infected mice also showed a severe necrotizing bronchi-
tis with associated alveolitis (Fig. 2g). The moderate-to-severe
alveolitis was characterized by abundant AMs and neutrophils
(Fig. 2h). Viral antigen commonly could be seen in necrotic
cellular debris within bronchial lumina and alveoli, and fre-
quently, within AMs. The virus-positive respiratory epithelial
cells (Fig. 2i and j) were infrequent in all groups, as evidenced
by the presence of only 0.05, 0.28, and 0.3 infected epithelial
cells/HPF in the rTx/91, wild-type Tx/91, and 1918 HA/NA:
Tx/91 virus-infected mouse lungs, respectively. The frequencies
of virus-positive macrophages in the alveoli were also low in
the Tx/91 control virus groups (0 and 1.35/HPF) (Fig. 2k), but
the frequency was at least threefold higher in the lungs of 1918
HA/NA:Tx/91 virus-infected mice (4.5/HPF). These histologi-
cal results indicate that neutrophils and AMs are prominent
cell types associated with and potentially mediating the severe
lung pathology, especially in alveoli, following lethal 1918
HA/NA recombinant virus infection.
Because of the observed increases of lung neutrophils and
their documented association with secondary bacterial infec-
tions, it was of interest to determine whether the 1918 HA/
NA:Tx/91 virus-infected lungs harbored levels of bacteria
greater than those in the Tx/91-infected or uninfected lungs.
Twenty individual samples from the BAL specimens collected
on days 0, 3, 5, and 7 p.i. (five per time period) and lung
homogenates collected on day 4 p.i (five mice per group) were
evaluated for the presence of bacteria. In general, there was no
tendency for bacteria to be isolated more frequently or at
higher levels from the 1918 HA/NA:Tx/91-infected mouse
lungs than from rTx/91-infected or uninfected lungs (data not
shown). For BAL specimens, 15% (3 of 20) of Tx/91-infected
and 20% (4 of 20) of uninfected mice were colonized with
bacteria, whereas 5% (1 of 20) of BAL samples collected from
the 1918 HA/NA:Tx/91-infected lungs demonstrated bacterial
growth. Among the positive BAL samples, bacterial growth
ranged from 102 to 103 CFU/ml. The proportions of lung
homogenates that yielded growth of bacteria were also similar
for all three groups tested. In these samples, no viable bacteria
were present in either normal or 1918 HA/NA:Tx/91-infected
lungs, and only one of five rTx/91-infected lung homogenates
presented low bacterial growth, which ranged from	101 to 102
CFU/ml among the triplicate samples tested. Taken together,
these results indicated that the HA and NA genes of the 1918
virus enhanced the virulence of the Tx/91 virus in mice and that
this enhancement does not appear to be due to a higher inci-
dence of coinfection with bacteria.
Neutrophils and alveolar macrophages contribute to host
defense after 1918 HA/NA:Tx/91 recombinant virus infection.
To better characterize the cellular components in the lung
following a primary 1918 HA/NA:Tx/91 virus infection, total
and differential cell counts of BAL sample infiltrates were
collected and analyzed from infected mice at 0.75 (18 h), 3, 5,
and 7 days p.i. (Table 2). The total BAL sample cells recovered
from both the 1918 HA/NA:Tx/91 virus-infected and control
Tx/91-infected mice showed increases of infiltrates as early as
18 h p.i., with cell numbers increasing 1.5- to 6.7-fold by day
7 p.i. However, much larger increases in total BAL sample cells
were observed in 1918 HA/NA:Tx/91 virus-infected lungs. Dur-
ing 1918 HA/NA:Tx/91 virus infection, peak cellular infiltra-
FIG. 1. Comparison of lung virus titers (A), weight loss rates (B),
and mortality rates (C) of BALB/c mice infected with 106 PFU of 1918
HA/NA:Tx/91 (Œ), rescued parental Tx/91 (F), and wild-type Tx/91
(■) virus. Four mice from each virus-infected group were euthanatized
on the indicated days p.i., and titers of individual lungs were deter-
mined in eggs. The limit of virus detection was 101.2 EID50/ml. The
remaining eight mice from each group were observed for weight loss
and mortality through a 14-day observation period. Asterisks indicate
that the 1918 HA/NA:Tx/91 lung titers are significantly (P 	 0.05)
different than those of both Tx/91 controls, as determined by ANOVA.
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FIG. 2. Pathologies of mice intranasally inoculated with 106 PFU of rescued parental Tx/91, 1918 HA/NA:Tx/91, or 1918 HA/NA:WSN
recombinant influenza viruses. Gross photographs (a and d) and photomicrographs (b, c, and e through h) of hematoxylin and eosin-stained tissue
sections are shown. (a) Lungs of a mouse inoculated with Tx/91 virus; lungs at day 5 p.i. appear normal except for a small focus of pneumonia in
left lung lobe. Bar 
 5 mm. (b) Mild lymphocytic peribronchitis with mild alveolitis in a mouse inoculated with Tx/91; day 5 p.i. Bar 
 200 m.
(c) Predominant peribronchial histiocytic alveolitis with iatrogenic atelectasis in a mouse inoculated with Tx/91; day 5 p.i. Bar 
 25 m. (d) Large
areas of pneumonia affecting most of the left lung and cardiac lobe of the right lung. Smaller areas of pneumonia in apical and azygous lobes of
the right lung of a mouse inoculated with 1918 HA/NA:Tx/91; day 5 p.i. Bar 
 5 mm. (e) Diffuse severe alveolitis in a mouse inoculated with 1918
HA/NA:Tx/91; day 5 p.i. Bar 
 200 m. (f) Severe neutrophilic-to-histiocytic alveolitis adjacent to bronchiole with necrotizing bronchitis.
Furthermore, some alveoli have pulmonary edema evident as protein crescents in a mouse inoculated with 1918 HA/NA:Tx/91; day 5 p.i. Bar 

20 m. (g) Severe necrotizing bronchitis with severe alveolitis in a mouse inoculated with 1918 HA/NA:WSN; day 5 p.i. Bar 
 100 m. (h) Higher
magnification of panel g showing prominent necrotic debris in bronchial lumen (labeled “B” within panel) and abundant neutrophils and histiocytes
in alveoli. Bar 
 20 m. (j) Two virus-positive bronchial epithelia (arrowheads) in a mouse inoculated with 1918 HA/NA:Tx/91; day 5 p.i. Bar 

10 m. (k) Virus-positive AMs (arrowheads) in a mouse inoculated with 1918 HA/NA:Tx/91; day 5 p.i. Bar 
 10 m.
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tion in the BAL samples on days 5 and 7 p.i. was associated
with a substantial increase in the number of infiltrating neu-
trophils compared with that for control Tx/91-infected mice.
The lymphocyte and macrophage cell counts of the 1918 HA/
NA:Tx/91 virus-infected lungs generally followed patterns sim-
ilar to those of counts for control mice, except elevated levels
of BAL sample macrophages were observed on days 3 and
5 p.i. These results suggest that 1918 HA/NA:Tx/91 virus in-
duces a predominant neutrophil infiltrate and moderate mac-
rophage increases into the mouse lung that may be contribut-
ing to the pathogenesis of the enhanced disease associated with
1918 HA/NA:Tx/91 virus infection.
The role of neutrophils and AMs in 1918 HA/NA recombi-
nant virus-induced lung pathology was investigated by elimi-
nating such cells before and/or after infection with 1918 HA/
NA:Tx/91 virus. Profound neutrophil depletion could be
achieved in BALB/c mice by MAb RB6-8C5 treatment. Blood
samples from two or three animals were collected 1 h before
each i.p. injection in order to monitor the neutrophil count.
The depletion protocol produced and maintained a depletion
of blood neutrophils in a range from 96 to 99% with no ap-
parent adverse affect on the percentages of lymphocytes and
macrophages (Fig. 3A). The MAb RB6-8C5 protocol of de-
pleting neutrophils was also efficient in the BAL samples with-
out noticeably affecting the percentages of lymphocytes and
macrophages (Table 2). Moreover, RB6-8C5 MAb was unable
to bind CD4 or CD8 T cells, thymocytes, monocytes/mac-
rophages, or B cells in flow cytometric experiments (38, 62;
also data not shown), suggesting that RB6-8C5 MAb has no
detectable cross-reactivity with these other cell types. Deple-
tion of AM was performed by i.n. instillation of L-Cl2MBP
twice (days 4 and 1) before infection. This procedure re-
sulted in an 82.7% reduction in AM numbers for BAL samples
compared with those for L-PBS-treated control mice on day
FIG. 3. Efficiency of neutrophil and AM depletion (depl) in vivo.
(A) Effect of neutrophil and AM depletion on blood leukocyte counts.
For neutrophil depletion, BALB/c mice received repeated i.p. injections
of MAb RB6-8C5 or control rat IgG beginning 5 h before i.n. virus
infection and on days 3, 5, and 7 after infection to maintain depletion.
Neutrophil depletion was monitored 1 h before each MAb injection by
performing differential cell counts on blood smears. The results at day
7 p.i. are shown and are expressed as the mean percentages of monocytes
(monos), neutrophils (PMNs), and lymphocytes (lymphs). (B) For AM
depletion, mice received 50-l doses of L-Cl2MBP i.n. on days4 and2
relative to the time of i.n. virus infection. Control mice received 50-l
doses of L-PBS (PBS-Lip). AM depletion was monitored on days 1, 3, 5,
and 7 p.i. by collecting cells from lung BAL samples from infected mice,
as described in Materials and Methods. The results at day 7 p.i. are shown
and are expressed as the number of AMs in the BAL sample.
TABLE 2. Total and differential counts in BAL specimens following infection with 1918 recombinant viruses
Infectiona Day p.i. Total cell yield( 105)b
Mean cell no. ( SE)/mousec
Neutrophils
( 103)
Lymphocytes
( 104)
Macrophages
( 104)
rTx/91 0 1.7 10.2 4.9 5.6 0.9 10.5 0.9
1918 HA/NA:Tx/91 0 1.8 10.8 4.3 5.9 1.2 10.9 1.2
rTx/91 0.75 2.3 12.8 3.1 6.7 0.6 14.9 1.5
1918 HA/NA:Tx/91 0.75 2.9 31.9 6.6 10.4 0.9 15.4 1.4
rTx/91 3 2.7 27 5.1 7.5  2.1 16.7 1.7
1918 HA/NA:Tx/91 3 5.0 60 19 15.0  2.3 28.5 3.6
rTx/91 5 3.7 51.8 10.5 15.4 1.5 15.9 1.9
1918 HA/NA:Tx/91 5 7.8 249.6 24.2 15.6 1.8 37.4 3.7
rTx/91 7 5.8 69.6 26.6 22.0 1.5 29.0 2.2
1918 HA/NA:Tx/91 7 12.1 798.6 73.2 13.3 4.2 27.8 5.5
1918 HA/NA:Tx/91, RB6-8C5 treatedd 7 6.7 1.2 2.6 27.8  1.6 47.3 1.7
1918 HA/NA:Tx/91, L-Cl2MBP
e 7 9.3 856 65.6 29.2 1.4 1.8  1.6
a Mice were i.n. infected with 106 PFU of the indicated viruses.
b BAL specimens were collected from five mice per group on the days indicated. Data are the mean absolute cell numbers in the BAL specimens.
c In each differential from five mice per group. Differential counts were performed on LeukoStat (Fisher Scientific)-stained cytospins.
d For neutrophil depletion, mice received repeated i.p. injections of MAb RB6-8C5 beginning 5 h before i.n. virus infection and on days 3 and 5 p.i.
e For AM depletion, mice received L-Cl2MBP i.n. on days 4 and 2 relative to the time of i.n. virus infection.
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2 p.i. (Fig. 3B) without adversely affecting the blood monocyte
percentages (Fig. 3A) or neutrophil numbers (Table 2). We
initially investigated whether depleting neutrophils and/or
AMs after infection would reduce the pathogenesis of the 1918
recombinant virus. Groups of 12 mice were i.n. infected with a
lethal dose (20 LD50) of 1918 HA/NA:Tx/91 virus, and treat-
ment with MAb RB6-8C5 or L-Cl2MBP was initiated on day
3 p.i. Control mice received rat IgG in place of MAb RB6-8C5
or L-PBS in place of L-Cl2MBP. Virus replication, weight loss,
and mortality rates among the neutrophil- and AM-depleted
mice were compared with those among their IgG- and L-PBS-
treated counterparts. Although neutrophils and AMs were
barely detectable in the lungs of the treated mice, depletion of
these two cell types initiated after 1918 HA/NA:Tx/91 virus
infection failed to reduce morbidity and mortality in compar-
ison with those for control animals (data not shown). Further-
more, the lethalities for the neutrophil-depleted, AM-de-
pleted, and control groups were 100%, with MDTs of 7.4, 7.1,
and 7.9, respectively. The amounts of infectious virus recovered
from the lungs of neutrophil-depleted and AM-depleted mice
were significantly (P	 0.05) higher (7.1 0.2 log10 EID50/ml and
7.4  0.2 log10 EID50/ml, respectively) in comparison to the
amount from untreated control mice (6.0  0.3 log10 EID50/ml),
suggesting that these cells suppress influenza growth in the lung.
In a second independent experiment, delaying neutrophil and/or
AM depletion until day 5 p.i also resulted in levels of morbidity
and mortality for treated animals that were comparable to those
for control animals (data not shown).
We next examined what effect neutrophil and/or AM deple-
tion would have if depletion was initiated before a sublethal
(0.2 LD50) 1918 HA/NA:Tx/91 virus infection. Accordingly,
groups of mice (20 per group) were depleted of neutrophils (by
MAb RB6-8C5 treatment) and/or depleted of AMs. At various
times following sublethal virus infections with 1918 HA/NA:
Tx/91 virus, the lung and brain tissues of MAb RB6-8C5- and
L-Cl2MBP-treated mice were collected for determination of
infectious virus titers. Figure 4A shows that the mean virus titers
in the lung were significantly higher at each time period examined
in neutrophil- and/or AM-depleted animals compared with those
of the controls. Infectious virus was also present in the brains of
MAb RB6-8C5-treated and/or L-Cl2MBP-treated mice (Fig. 4B)
but was not detected in the control animals. At the sublethal
infectious dose of 1918 HA/NA:Tx/91 virus, symptoms of
hunched posture, lethargy, and death were not observed in un-
treated control animals. However, we found that most neutrophil-
and/or AM-depleted mice lost significant amounts of weight and
were listless during the first week of infection; these symptoms
were taken as signs of morbidity (data not shown). All AM-
depleted mice succumbed to infection by day 8, whereas 4 of 10
mice depleted of neutrophils died (Fig. 4C). All mice depleted
of both AMs and neutrophils rapidly succumbed to virus in-
fection, and death occurred slightly sooner than it did in
groups depleted of AM or neutrophils only. In contrast, all
L-PBS and rat IgG control mice survived the sublethal virus
infection. In a second independent experiment, both neutro-
phils and AMs were depleted before a sublethal virus infection
with 0.2 LD50 of 1918 HA/NA:Tx/91 virus or 10
6 PFU of rTx/91
virus. All depleted mice challenged with 104 PFU 1918 HA/
NA:Tx/91 virus died. In contrast, we did not observe any
change in morbidity or mortality in mice challenged with 106
PFU of rTx/91 virus. These results demonstrate that AMs and
neutrophils play a significant role in controlling the replication
and spread of 1918 HA/NA:Tx/91 virus after infection.
Cytokine and chemokine expression in lungs of 1918 HA/
NA-infected mice. Following primary infection of mice with
influenza A viruses, many cytokines and chemokines are pro-
duced in the lung (7, 27, 63) and are believed to contribute to
the recruitment/activation of protective immune cells, thus
facilitating the antiviral defense against influenza infection.
FIG. 4. Depletion (depl.) of neutrophils (PMN) and AM results
in increased lung virus titers (A), brain virus titers (B), and lethality
(C). Neutrophils were depleted in BALB/c mice (20 mice/group) by
repeated i.p. injections of MAb RB6-8C5 (Œ) or control rat IgG (F)
5 h before a 1918 HA/NA:Tx/91 virus infection and on days 3, 5, and
7 p.i to maintain depletion. For AM depletion, i.n. administration of
50 l of L-Cl2MBP () on days 4 and 2 relative to the time of
1918 HA/NA:Tx/91 virus infection was performed. Control mice
received 50-l doses of L-PBS (E). An additional group of mice was
depleted of both AMs and neutrophils (}). Mice were i.n. infected
with sublethal doses of 0.2 LD50 of 1918 HA/NA:Tx/91 virus. On the
days indicated, mice (four per group) were sacrificed, and individual
lung and brain tissues were homogenized in 1 ml of PBS. The titers
of the lysates for virus infectivity in eggs were determined. The
remaining eight mice were followed daily for survival. The key
corresponds to panels A and B. Asterisks indicate that the control
lung titers are significantly (P 	 0.05) different from lung titers from
depleted mice, as determined by ANOVA.
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Individual lung tissues were collected on day 5 p.i., a time point
with maximal lung cytokine/chemokine levels following infec-
tion with highly pathogenic influenza strains (63). Tissues were
homogenized, and lysates were assayed for cytokines and che-
mokines by ELISA. Determination of IFN-, IFN-, TNF-,
MIP-1, and MIP-2 levels demonstrated that all cytokines and
chemokines were produced above their constitutive levels 5
days after infection with both 1918 HA/NA:Tx/91 and rTx/91
virus (Fig. 5A). Although the lung IFN- levels were similar
for both virus-infected groups, IFN-, TNF-, and both
MIP-1 and MIP-2 chemokines were detected at significantly
higher levels in 1918 HA/NA:Tx/91-infected mice than in Tx/
91-infected mice. Concentrations of TNF- were low com-
pared with concentrations of the other cytokines measured, but
protein levels of this cytokine in 1918 HA/NA:Tx/91-infected
mice were fourfold higher than those in Tx/91-infected mice.
Since the previous experiments established that AM and
neutrophils play a significant role in helping control the repli-
cation and spread of the 1918 HA/NA:Tx/91 virus after i.n.
infection, we next determined whether these cells influenced
the expression of cytokines/chemokines associated with virus
infection. We found that neutrophil depletion was accompa-
nied by a significant reduction of cytokine and chemokine
expression in the infected lungs (Fig. 5B). Compared with
expression in rat IgG control mice, IFN- and IFN- levels
were decreased by 81% and 87%, respectively, and TNF- and
MIP-2 levels fell by 24% and 37%, respectively. The level of
the beta chemokine MIP-1 was also significantly lower (55%)
in mice depleted of neutrophils than that in nondepleted con-
trol mice. Treatment of naı¨ve mice with L-PBS or L-Cl2MBP
alone did not increase the production of detectable lung cyto-
kines or chemokines above the constitutive levels. AM-de-
pleted mice also had decreased cytokine levels in the lungs
following 1918 HA/NA:Tx/91 virus infection. Marked de-
creases in IFN-, IFN-, TNF-, and MIP-1 levels were ob-
served in AM-depleted mice, whereas the level of MIP-2 was
moderately reduced compared with cytokine levels in the L-
PBS control mice. These results suggest that the 1918 HA/NA
glycoproteins possess molecular determinants that are capable
of inducing high levels of cytokines/chemokines in the mouse
lung and that AMs and neutrophils are crucial for their optimal
production.
DISCUSSION
During the 1918 influenza pandemic, pathologists observed
at autopsy severe destruction of lung tissue unlike that typically
seen in cases of pneumonia. Histological observations of ar-
chived fixed tissues from 1918 showed heavy infiltrations of
white blood cells into influenza-infected lungs, including the
alveoli, suggesting that such cells were involved in the patho-
genesis of disease (35, 71, 72). The studies described herein
were based on a previous observation that the lethal 1918
HA/NA:WSN recombinant influenza virus and the nonlethal
New Caledonia HA/NA:WSN control virus induced markedly
different patterns of mouse lung inflammation (30). Although
both viruses induced a necrotizing bronchitis, which is charac-
teristic of uncomplicated influenza virus infections, histological
samples of the lungs of 1918 HA/NA:WSN-infected mice also
displayed moderate-to-severe alveolitis characterized by in-
creases of AMs and neutrophils. Kobasa et al. (34) also ob-
served histologically a massive recruitment of neutrophils into
the mouse lung following an intranasal infection of a 1918 HA
recombinant virus. In the current study, a recombinant virus
possessing the 1918 HA and NA genes on the genetic back-
ground of a Tx/91 virus replicated efficiently in the mouse lung
and was lethal for this species, with an MDT of 7.3 to 7.9 days.
FIG. 5. Lung cytokine/chemokine activity in 1918 HA/NA:Tx/91
virus-infected lungs (A) and AM- and/or neutrophil (PMN)-depleted
(depl.) mice (B). At day 5 p.i., five individual lung tissues were re-
moved from each treated group and frozen at 70°C. Samples were
thawed and homogenized in 1 ml of PBS, after which the clarified cell
lysates were assayed by ELISA. The mean cytokine level  standard
deviation for each cytokine was determined. In addition, the constitu-
tive cytokine level present in each tissue was determined by harvesting
individual lung tissues from four uninfected BALB/c mice. The con-
stitutive lung cytokine levels were 22, 27, and 35 pg/ml for IFN-,
IFN-, and TNF-, respectively. The constitutive lung chemokine lev-
els were 14 and 17 pg/ml for MIP-1 and MIP-2, respectively. (A) As-
terisks indicate that the levels for the 1918 HA/NA:Tx/91-infected
group were significantly (P 	 0.05) different from those for the Tx/91-
infected control group, as determined by ANOVA. (B) For AM de-
pletion, mice received 50-l doses of L-Cl2MBP i.n. on days 4 and
2 relative to the time of 1918 HA/NA:Tx/91 virus infection. Control
mice received 50-l doses of L-PBS. For neutrophil depletion, mice
received i.p. injections of MAb RB6-8C5 or control rat IgG beginning
5 h before 1918 HA/NA:Tx/91 virus infection and on day 3 after
infection to maintain depletion until the day of tissue collection (day
5 p.i.). Asterisks indicate that the control lung cytokine/chemokine
levels are significantly (P 	 0.05) different than those detected in
depleted mice, as determined by ANOVA.
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Severe disease following 1918 HA/NA:Tx/91 virus infection
was dose dependent, with only high doses of virus (105 PFU)
causing significant morbidity and mortality. In contrast, the
parental Tx/91 H1N1 virus did not cause mortality in mice at
any virus dose and replicated to only low titers in mouse lungs.
Thus, the 1918 HA/NA genes conferred upon the Tx/91 inter-
nal gene complex the property to grow to high titers in the
respiratory tract without the need for prior adaptation, which
is generally required for the replication of human H1N1 vi-
ruses in mice (28). In comparison to the Tx/91-infected control
lungs, the 1918 HA/NA:Tx/91-infected lungs displayed a heavy
inflammatory infiltration marked by a predominance of neu-
trophils associated with an increase of AMs and cytokines
shortly before the death of these mice. To address the func-
tional role of neutrophils and AMs during 1918 HA/NA:Tx/91
virus infection, we depleted mice of these cells and determined
the severities of disease and degrees of virus clearance. In
comparison to immunocompetent controls, AM- and neutro-
phil-depleted mice displayed higher virus titers in the lung
tissue, which spread systemically to the brain after infection
from an otherwise sublethal dose in nondepleted animals. In
addition, depletion of neutrophils and/or AMs resulted in sig-
nificantly lower levels of cytokines and chemokines in infected
lung tissues. As a consequence, AM- and/or neutrophil-de-
pleted mice displayed greater morbidity and mortality follow-
ing sublethal 1918 HA/NA:Tx/91 virus infection.
It is unclear why the lethal 1918 HA/NA:Tx/91 and parental
Tx/91 strains of influenza vary in their capacities to induce
neutrophil migration into the mouse lung, particularly the al-
veoli. In the recipients of the Tx/91 control virus infections,
lung tissues displayed a relatively modest inflammatory re-
sponse accompanied by clearance of infectious virus and viral
antigen by day 8 p.i. The inflammatory cells in these lungs
appear restricted to the level of the bronchial epithelium and
parabronchial area. In contrast, 1918 HA/NA:Tx/91 virus in-
fection induced an increase in neutrophils that could be de-
tected as early as 18 h after infection, and by day 5 the neu-
trophil influx was evident both in the peribronchium and
alveoli. Furthermore, the pulmonary neutrophilia did not ap-
pear to be due to a higher incidence of coinfection with bac-
teria but was associated with higher titers of infectious virus
and greater detected levels of viral antigen, including in the
alveoli. However, the extent of viral replication alone does not
appear to account for the enhanced mouse lung pathology
observed among 1918 recombinant viruses (30, 34). Further
studies to elucidate the actual stimuli for neutrophil accumu-
lation into the mouse lung are under way. A variety of inflam-
matory mediators, including complement factors (29) and che-
mokines (7, 55), could cause neutrophil migration. Chemokine
expression closely follows the level of influenza virus replica-
tion and affects the type of inflammatory response to infection
(68). We focused on MIP-1 and MIP-2, since these chemo-
kines have been shown to activate and exert chemotactic ef-
fects on neutrophils, although MIP-1 is also a potent che-
moattractant for monocytes and activated T cells (73, 75). It
has been demonstrated that influenza-infected mice carrying a
disrupted MIP-1 (/) gene have reduced inflammation and
delayed clearance of the virus when compared with infected
wild-type (/) mice (7); thus, MIP-1 may play an important
role during influenza virus infection. The greater expression of
MIP-1 and MIP-2 chemokines in the 1918 HA/NA:Tx/91-
infected lungs relative to those in Tx/91-control lungs corre-
lates well with the increased neutrophil influx observed on days
5 and 7 p.i.
Conceivably, excessive accumulation of neutrophils and
AMs in a vital organ, such as the lung, could contribute to
tissue damage by causing vascular injury and destruction of the
parenchymal cells (2, 37). The resulting loss of functional al-
veolar surface area would result in inadequate gas exchange,
lower respiration, and, ultimately, death. In fact, deterioration
of pulmonary function has been observed in patients with pro-
longed neutropenia (2). Furthermore, the overproduction of
cytokines, such as IFN- and TNF-, may be detrimental to
the host and may be responsible for the enhanced morbidity
and mortality by influenza virus infection (8, 11, 57, 60). In-
creased expression of TNF- has been associated with highly
pathogenic influenza H5N1 viruses in vitro and has been noted
in postmortem lung tissue of H5N1 fatal cases (6, 42). TNF-
can also function to enhance neutrophilic infiltration into the
lung tissue (33). We found that the expression of TNF- was
two- to threefold higher in the 1918 HA/NA:Tx/91-infected
lungs preceding the death of these mice (day 5 p.i.) than that
in to Tx/91-infected control lungs. Analysis of IFN- cytokine
levels in 1918 HA/NA:Tx/91-infected mouse lungs also demon-
strated a significant increase over that in Tx/91-infected control
lungs. Neutrophils elicit numerous responses in the presence of
IFN-; these responses may include increased oxidative burst,
induction of antigen presentation, and chemokine production (12,
13). The neutrophils in the 1918 HA/NA:Tx/91-infected lungs
may have been one source of the cytokines and chemokines that
were observed, since neutrophil depletion resulted in significantly
lower levels of TNF-, IFN-, and both MIP chemokines. Migra-
tion of neutrophils into the lung is thought to occur in a cascading
manner. In a cycle that repeats itself, infiltrating neutrophils and
AMs produce more cytokines/chemokines, which in turn che-
moattract additional cells into the lung and thus increase lung
inflammation (54, 77).
The notion of neutrophils and AMs driving the increased
lung pathology and contributing to mortality following 1918
HA/NA:Tx/91 virus infection was addressed in our initial de-
pletion studies. However, we found that the depletion of neu-
trophils and/or AMs after the initiation of lung inflammation
had no effect on the overall disease outcome following lethal
challenge with the 1918 HA/NA recombinant virus. Thus, de-
spite effective and substantial depletion of neutrophils and
AMs in the lungs of treated animals, these mice displayed
severe morbidity and had MDTs in the range of those of
untreated control animals (7.1 to 7.4 days). However, it was
observed in these initial experiments that delayed depletion
caused slightly greater viral burden in the infected lungs, sug-
gesting that these cells may function either directly or indi-
rectly to control virus replication in the lung. We subsequently
found that if mice were depleted of neutrophils and/or AMs
before a sublethal infection with 1918 HA/NA:Tx/91 virus, the
animals displayed significant weight loss and increased mortal-
ity. Furthermore, the virus spread systemically to the brain, a
property not seen with the immunocompetent control mice
infected with the 1918 HA/NA:Tx/91 virus. These results sug-
gest that although neutrophils are the predominant cell in
the 1918 HA/NA:Tx/91-infected lung and may contribute to
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the pathology, they are essential for host defense by con-
trolling the replication and spread of virus after a primary
infection. This antiviral role of neutrophils extends the find-
ings of previous studies (16, 17, 41, 61), including those that
identified antiviral substances with IFN-like activity against
human and bovine herpes viruses (53). It remains unresolved
how neutrophils exert their antiviral effect against influenza, as
their defense capabilities are quite diverse. Neutrophils have
been shown to adhere to influenza virus-infected cells and to
phagocytose influenza virions in vitro (16, 46). It has become
clear that mature neutrophils, although limited in their capac-
ity to synthesize and secrete proteins, nevertheless produce a
variety of mediators, some of which may have antiviral activity.
The production of immune mediators, such as myeloperoxi-
dase (76), defensins (18), and reactive oxygen and/or nitrogen
species (16, 56), by activated neutrophils may directly inhibit
influenza growth in the lung. The production of IFN- or
antiviral cytokines, such as TNF-, has antiviral activity against
influenza (45, 75).
Our results also show that the elimination of AM has a
dramatic effect on the host defense to 1918 HA/NA:Tx/91 virus
infection. While only some of the neutrophil-depleted mice
died following a sublethal 1918 HA/NA:Tx/91 virus infection,
100% mortality was observed for AM-depleted mice. Similar
to the response with neutrophil depletion, we found that in the
absence of AMs, mice were unable to control 1918 HA/NA:
Tx/91 virus infection or its spread to the brain tissues. This
does not appear to be due to impaired neutrophil recruitment
in AM-depleted lungs, because neutrophils are recruited in
large numbers in 1918 HA/NA:Tx/91-infected lungs but cannot
functionally compensate for the antiviral functions of the de-
pleted AM. The exact mode of action of AMs in controlling
1918 HA/NA:Tx/91 virus replication remains to be revealed.
Most likely, AMs can phagocytose virus particles in the lung
(54) and synthesize critical immune mediators, including nitric
oxide (43) and cytokines (77). AMs can also regulate cell-
mediated immune responses to influenza infection (60, 69).
The significant reduction of cytokines and chemokines in AM-
depleted mice would suggest that AMs play an important role
as a cytokine source during the early stages of infection.
One explanation for the apparent alveolar tropism of the
1918 recombinant viruses may be that it is partly due to the
ability of the 1918 HA to target certain cell types in the mouse
lung alveoli. The HA surface glycoprotein possesses receptor-
binding properties that determine the host range of influenza
by binding to cell surface glycoproteins containing terminal
sialic acid residues. The nature of the receptor sialic acid link-
age to a neighboring galactose can occur in the alpha 2,3
linkage or the alpha 2,6 linkage. Although both Tx/91 and 1918
HAs have a preference for binding 2,6-linked sialic acids (21),
differences in binding affinities or in binding specificities to
different glycosugars might be responsible for an expanded cell
tropism of the 1918 recombinant viruses that results in in-
creased replication in the lungs. Alternatively, the 1918 HA
and/or NA proteins might confer upon the virus an increased
ability to evade the antiviral host response. In fact, influenza
H1 and H3 subtypes have been shown to deactivate neutrophil
functions that appear to be mediated by HA binding to neu-
trophil surface sialic acid-bearing sites (24). Further studies are
needed to determine the composition of the sialic acid in the
deeper airways
of the alveoli and to determine whether the receptor affinity of
the 1918 HA increases the cellular tropism for resident cells of
the alveoli.
Arguably, the 1918 pandemic influenza virus was successful
because of its ability to replicate efficiently in hosts with little or
no immunity to the virus of the H1N1 subtype. However, its
ability to induce severe lung pathology, particularly in young
adults, suggests that host factors contributed to the high viru-
lence of this virus. In this study, a recombinant virus containing
the 1918 HA and NA glycoproteins prepared on the genetic
background of a nonlethal influenza H1N1 1991 strain gave the
virus a lethal phenotype in mice. More striking still were the
high titers of virus in the lungs of these mice, which were
associated with an influx of substantial numbers of neutrophils
and macrophages into the infected lung, particularly the alve-
oli. While the AMs and neutrophils may be contributing to the
overall pathogenesis, due to their presence in the airways, their
role is crucial in controlling the growth and promoting clear-
ance of this highly virulent virus. These results may have im-
portant implications in defining the pathogenesis of severe
influenza virus infections caused by highly virulent influenza
strains.
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